What Are the Limitations of Using DrugBank API in Cancer Research?
While the DrugBank API is a valuable resource, there are some limitations to consider:
Data completeness: Not all drugs may have comprehensive data available, particularly newer or less-studied compounds Data accuracy: As with any database, there may be errors or outdated information Integration challenges: Combining DrugBank data with other sources can be complex and may require specialized expertise Access restrictions: Some features of the API may require a subscription or institutional access
